SG11202108752YA - Process for the preparation of a substituted imidazoquinoline - Google Patents
Process for the preparation of a substituted imidazoquinolineInfo
- Publication number
- SG11202108752YA SG11202108752YA SG11202108752YA SG11202108752YA SG11202108752YA SG 11202108752Y A SG11202108752Y A SG 11202108752YA SG 11202108752Y A SG11202108752Y A SG 11202108752YA SG 11202108752Y A SG11202108752Y A SG 11202108752YA SG 11202108752Y A SG11202108752Y A SG 11202108752YA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- substituted imidazoquinoline
- imidazoquinoline
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019055793 | 2019-03-07 | ||
| PCT/EP2020/056047 WO2020178434A1 (en) | 2019-03-07 | 2020-03-06 | Process for the preparation of a substituted imidazoquinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108752YA true SG11202108752YA (en) | 2021-09-29 |
Family
ID=69723965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108752YA SG11202108752YA (en) | 2019-03-07 | 2020-03-06 | Process for the preparation of a substituted imidazoquinoline |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20220144822A1 (en) |
| EP (1) | EP3935047B1 (en) |
| JP (1) | JP7576038B2 (en) |
| KR (1) | KR20210136033A (en) |
| CN (1) | CN113518775B (en) |
| AU (1) | AU2020231822A1 (en) |
| BR (1) | BR112021016960A2 (en) |
| CA (1) | CA3132229A1 (en) |
| CL (1) | CL2021002322A1 (en) |
| CO (1) | CO2021011258A2 (en) |
| CU (1) | CU24679B1 (en) |
| DK (1) | DK3935047T3 (en) |
| ES (1) | ES2992926T3 (en) |
| IL (1) | IL286054A (en) |
| MX (1) | MX2021010669A (en) |
| PH (1) | PH12021552106A1 (en) |
| SG (1) | SG11202108752YA (en) |
| WO (1) | WO2020178434A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023083439A1 (en) * | 2021-11-09 | 2023-05-19 | BioNTech SE | Tlr7 agonist and combinations for cancer treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451810B1 (en) | 1999-06-10 | 2002-09-17 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6573273B1 (en) | 1999-06-10 | 2003-06-03 | 3M Innovative Properties Company | Urea substituted imidazoquinolines |
| US6756382B2 (en) | 1999-06-10 | 2004-06-29 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| PE20040945A1 (en) * | 2003-02-05 | 2004-12-14 | Warner Lambert Co | PREPARATION OF SUBSTITUTED QUINAZOLINES |
| WO2005051324A2 (en) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| WO2008135791A1 (en) | 2007-05-08 | 2008-11-13 | Astrazeneca Ab | Imidazoquinolines with immuno-modulating properties |
| RS53059B (en) | 2008-03-24 | 2014-04-30 | 4Sc Discovery Gmbh | Novel substituted imidazoquinolines |
| JP2013512859A (en) | 2009-12-03 | 2013-04-18 | 大日本住友製薬株式会社 | Imidazoquinoline acting through a toll-like receptor (TLR) |
| US8735386B2 (en) * | 2010-07-23 | 2014-05-27 | Boehringer Ingelheim International Gmbh | Aminopyrazoloquinazolines |
| UA113280C2 (en) * | 2010-11-11 | 2017-01-10 | AMINOSPIRT-SUBSTITUTED Derivatives of 2,3-Dihydroimimidase $ 1,2-c] QINAZOLINE, SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, DISEASES AND DISEASES | |
| CN108794467A (en) | 2017-04-27 | 2018-11-13 | 博笛生物科技有限公司 | 2- amino-quinoline derivatives |
| WO2019048036A1 (en) * | 2017-09-06 | 2019-03-14 | Biontech Ag | Substituted imidazoquinolines |
| IL273039B2 (en) * | 2017-09-06 | 2023-10-01 | BioNTech SE | Transduced imidazoquinolines as TLR7 agonists |
-
2020
- 2020-03-06 DK DK20707669.6T patent/DK3935047T3/en active
- 2020-03-06 PH PH1/2021/552106A patent/PH12021552106A1/en unknown
- 2020-03-06 MX MX2021010669A patent/MX2021010669A/en unknown
- 2020-03-06 CA CA3132229A patent/CA3132229A1/en active Pending
- 2020-03-06 SG SG11202108752YA patent/SG11202108752YA/en unknown
- 2020-03-06 ES ES20707669T patent/ES2992926T3/en active Active
- 2020-03-06 EP EP20707669.6A patent/EP3935047B1/en active Active
- 2020-03-06 BR BR112021016960A patent/BR112021016960A2/en unknown
- 2020-03-06 US US17/432,017 patent/US20220144822A1/en active Pending
- 2020-03-06 CU CU2021000071A patent/CU24679B1/en unknown
- 2020-03-06 WO PCT/EP2020/056047 patent/WO2020178434A1/en active Application Filing
- 2020-03-06 CN CN202080018804.8A patent/CN113518775B/en active Active
- 2020-03-06 AU AU2020231822A patent/AU2020231822A1/en active Pending
- 2020-03-06 JP JP2021552887A patent/JP7576038B2/en active Active
- 2020-03-06 KR KR1020217029506A patent/KR20210136033A/en active Pending
-
2021
- 2021-08-26 CO CONC2021/0011258A patent/CO2021011258A2/en unknown
- 2021-09-01 IL IL286054A patent/IL286054A/en unknown
- 2021-09-06 CL CL2021002322A patent/CL2021002322A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020178434A1 (en) | 2020-09-10 |
| IL286054A (en) | 2021-10-31 |
| JP2022525023A (en) | 2022-05-11 |
| EP3935047A1 (en) | 2022-01-12 |
| CU24679B1 (en) | 2023-09-07 |
| CO2021011258A2 (en) | 2021-09-09 |
| CU20210071A7 (en) | 2022-04-07 |
| CL2021002322A1 (en) | 2022-05-13 |
| MX2021010669A (en) | 2021-09-28 |
| JP7576038B2 (en) | 2024-10-30 |
| KR20210136033A (en) | 2021-11-16 |
| US20220144822A1 (en) | 2022-05-12 |
| CA3132229A1 (en) | 2020-09-10 |
| CN113518775B (en) | 2024-10-29 |
| CN113518775A (en) | 2021-10-19 |
| ES2992926T3 (en) | 2024-12-19 |
| PH12021552106A1 (en) | 2022-05-30 |
| DK3935047T3 (en) | 2024-09-09 |
| BR112021016960A2 (en) | 2021-11-23 |
| AU2020231822A1 (en) | 2021-08-26 |
| EP3935047B1 (en) | 2024-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286566A (en) | Process for the preparation of microbiocidal oxadiazole derivatives | |
| IL276917A (en) | Process for the preparation of elobixibat | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| SG11202108238VA (en) | Process for the preparation of methionine | |
| RS64534B1 (en) | Process for the preparation of n-alkyl-nitratoethylnitramines | |
| IL289904A (en) | Process for the preparation of biphenylamines | |
| IL285550A (en) | Process for the preparation of polyamides | |
| IL281254A (en) | Process for the preparation of lenvatinib | |
| IL275381A (en) | A process for the preparation of crisaborole | |
| IL286054A (en) | Process for the preparation of a substituted imidazoquinoline | |
| GB2616171B (en) | Process for Making Levoamphetamine | |
| FI20185934A (en) | Process for the preparation of arylsulfonylpropenenitriles | |
| GB201909178D0 (en) | Methods for preparing compounds | |
| IL290181A (en) | Process for the preparation of fluensulfone | |
| IL290215A (en) | Process for preparing the crystalline form ii of sotagliflozin | |
| IL286006A (en) | Process for preparing 4-amino-5-methylpyridone | |
| IL283633A (en) | Process for the preparation of a cyclic dinucleotide | |
| ZA202102159B (en) | Process for the preparation of a flavouring | |
| EP3294703A4 (en) | A process for the preparation of verapamil hydrochloride | |
| IL280312A (en) | Process for the preparation of bromodomain inhibitor | |
| EP4021920A4 (en) | An improved process for the preparation of etelcalcetide hydrochloride | |
| IL276557A (en) | Process for the preparation of metformin | |
| HUP1800278A2 (en) | Process for the preparation of boc-linagliptin | |
| PL3599256T3 (en) | Process for the preparation of polyorganosiloaxnes | |
| GB201909188D0 (en) | Methhods for preparing compounds |